200 Billion Reasons to Invest in Nvidia Stock

Nvidia reported Q1 fiscal 2027 revenue of $81.6 billion, up 85% year over year and above both internal guidance and analyst estimates, with adjusted EPS of $1.87, up 140%. Management also reiterated strong Q2 guidance and highlighted a new $200 billion TAM for its Vera CPU, with nearly $20 billion of CPU revenue visible this year. The article argues Nvidia’s AI growth story remains intact and could expand further into agentic AI and CPUs.

Analysis

The market is still treating NVDA as a single-product GPU story, but the more important read-through is that the company is trying to reprice itself as the default compute platform for the entire AI stack. If Vera plus Rubin can win even a modest share of inference-oriented CPU demand, the earnings mix shifts from a capital-cycle beneficiary to a platform vendor with a longer-duration annuity, which should support a higher terminal multiple than the market is assigning today.

Second-order winners are the ecosystem names that sit behind incremental deployment, not the obvious GPU competitors. More agentic workloads mean more networking, memory bandwidth, power delivery, and rack-level integration pressure; that tends to pull demand through the entire AI datacenter bill of materials and leaves AMD/INTC fighting for a market that may expand but still price-pressures gross margins. The key subtlety is that NVDA does not need CPU share dominance to matter — even low-teens share in a new TAM can be more incremental to FCF than a larger share in a mature market.

The main risk is timing mismatch: the market may be extrapolating a 12-24 month adoption curve for agentic AI, while enterprise deployment and software optimization could take multiple budget cycles. If inference spending shifts slower than management implies, the CPU thesis becomes a narrative premium without near-term earnings proof, creating downside if growth decelerates from hypergrowth to merely strong growth. In that scenario, the stock is vulnerable to multiple compression even if fundamentals remain best-in-class.

Contrarian view: the consensus may be underestimating how much of this opportunity NVDA can monetize without taking much share from AMD/INTC, because owning the reference architecture can be more valuable than owning the socket. The more interesting trade is not betting against NVDA outright, but fading names that depend on server refresh optimism while the AI platform vendor broadens its attach rate across CPU, GPU, and system-level infrastructure.

Key Decisions for Investors

• Maintain a core long NVDA position for 6-12 months; add on post-earnings weakness only if implied growth expectations reset another 5-8% without a change in capex commentary.
• Pair trade: long NVDA / short AMD over the next 3-6 months. The setup favors NVDA monetizing a broader architecture while AMD faces the harder task of defending share in both GPUs and CPUs; target a 10-15% relative outperformance, stop if AMD shows material design-win acceleration.
• Underweight INTC on rallies for 6-9 months. If agentic inference adoption is real, the market may overcredit Intel’s CPU relevance before NVDA’s software and platform integration displace socket-level thinking; use strength to build shorts with tight risk controls.
• Buy NVDA calls on 3-6 month dips rather than chasing highs; structure around post-guidance volatility because the payoff is convex if CPU revenue ramps faster than expected, but theta is expensive if adoption is slower.
• Watch for a confirmation basket long: NVDA plus a datacenter infrastructure name. If inference capex broadens, the second-order beneficiaries should outperform over the next 2-4 quarters.